People and Business — 3/21
Industry happenings from the last month, all in one place.
People news
Elligo Health Research welcomed Vice President, Healthcare Partnerships Katie Eyestone, Chief People Officer Kathleen Fairall, and Vice President, Practice Success Vanessa Watson to its leadership team.
Worldwide Clinical Trials, Inc. announced that Gary Fishbein, MD, MPH, is its new executive medical director and medical lead for oncology, as well as that Jose L. Martinez, MD, has joined as senior medical director for oncology.
Trialbee announced the appointment of Craig Lipset as Chairman of the Trialbee Industry Advisory Board.
Deep 6 AI announced the addition of Jason Attanucci as Vice President of Life Sciences.
Firma Clinical recently commenced a Scientific Advisory Board for its clinical services, including biometrics/data. Members include Greg Campbell, PhD, Ming-Hui Chen, PhD, Ying Lu, PhD, L.J. Wei, PhD, Eugenia Henry, PhD, and Earl Webb Henry, MD.
Business news
Avance Clinical celebrated their strategic partnership with Medidata, and the accreditation of seven Medidata inhouse experts.
KCR announced the establishment of a new branch in Sydney, Australia.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
